開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
上期所:本週銅庫存增加19817噸,鋁庫存減少18300噸,鋅庫存增加1181噸,鉛庫存減少209噸,鎳庫存減少771噸,錫庫存增加56噸,天然橡膠庫存減少5716噸。
2026-08-21
上期所:本週銅庫存增加19817噸,鋁庫存減少18300噸,鋅庫存增加1181噸,鉛庫存減少209噸,鎳庫存減少771噸,錫庫存增加56噸,天然橡膠庫存減少5716噸。
返回
其他消息
2026-08-20
U.S. Treasury Secretary Bessent said on Iran that maximum economic pressure suggests military action may not be resumed, and that the oil market has misread the implications of that pressure.
U.S. Treasury Secretary Bessent said on Iran that maximum economic pressure suggests military action may not be resumed, and that the oil market has misread the implications of that pressure.
2026-08-21
Changchun High & New said on Aug. 20 in an investor call that Baike Biotech has established multiple R&D platforms including an mRNA vaccine platform and is expanding its applications. As of end-June 2026, Baike’s self-developed HSV-2 vaccine is in Phase I. Baike’s equity-investee, Chuanxin Biopharma (Suzhou) — which Baike will acquire up to 100% subject to milestone conditions under the parties’ agreement — is conducting an investigator-initiated trial (IIT) of a pan-tumor mRNA vaccine, TMT101,
Changchun High & New said on Aug. 20 in an investor call that Baike Biotech has established multiple R&D platforms including an mRNA vaccine platform and is expanding its applications. As of end-June 2026, Baike’s self-developed HSV-2 vaccine is in Phase I. Baike’s equity-investee, Chuanxin Biopharma (Suzhou) — which Baike will acquire up to 100% subject to milestone conditions under the parties’ agreement — is conducting an investigator-initiated trial (IIT) of a pan-tumor mRNA vaccine, TMT101, at Peking Union Medical College Hospital.
Chat with us
, powered by
LiveChat